The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analyses.
暂无分享,去创建一个
Isabelle Boutron | Philippe Ravaud | Raphaël Porcher | Ignacio Atal | R. Porcher | I. Boutron | P. Ravaud | Ignacio Atal
[1] G. Guyatt,et al. How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature. , 2014, JAMA.
[2] G. Guyatt,et al. GRADE guidelines 6. Rating the quality of evidence--imprecision. , 2011, Journal of clinical epidemiology.
[3] Z. Alfirevic,et al. Instruments for chorionic villus sampling for prenatal diagnosis. , 2003, The Cochrane database of systematic reviews.
[4] Philippe Ravaud,et al. Reporting of sample size calculation in randomised controlled trials: review , 2009, BMJ : British Medical Journal.
[5] J. Ioannidis,et al. Evolution of Reporting P Values in the Biomedical Literature, 1990-2015. , 2016, JAMA.
[6] Marc Buyse,et al. Data fraud in clinical trials. , 2015, Clinical investigation.
[7] L. Trinquart,et al. Association between analytic strategy and estimates of treatment outcomes in meta-analyses. , 2014, JAMA.
[8] B. Chase Kruse,et al. Unbreakable? An analysis of the fragility of randomized trials that support diabetes treatment guidelines. , 2017 .
[9] Isabelle Boutron,et al. Misrepresentation and distortion of research in biomedical literature , 2018, Proceedings of the National Academy of Sciences.
[10] David Moher,et al. Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study , 2017, British Medical Journal.
[11] F. Farrokhyar,et al. Fragility of Results in Ophthalmology Randomized Controlled Trials: A Systematic Review. , 2017, Ophthalmology.
[12] L. Mbuagbaw,et al. Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis. , 2013, The Cochrane database of systematic reviews.
[13] Andrew Burke,et al. The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index. , 2014, Journal of clinical epidemiology.
[14] R. Perera,et al. Impact of heterogeneity and effect size on the estimation of the optimal information size: analysis of recently published meta-analyses , 2017, BMJ Open.
[15] L. Trinquart,et al. Influence of trial sample size on treatment effect estimates: meta-epidemiological study , 2013, BMJ : British Medical Journal.
[16] Jonathan A C Sterne,et al. Sifting the evidence—what's wrong with significance tests? , 2001, BMJ : British Medical Journal.
[17] Nicola J Cooper,et al. Evidence‐based sample size calculations based upon updated meta‐analysis , 2007, Statistics in medicine.
[18] Isabelle Boutron,et al. Association between trial registration and treatment effect estimates: a meta-epidemiological study , 2016, BMC Medicine.
[19] Rickey E Carter,et al. The Fragility Index: a P-value in sheep’s clothing? , 2016, European heart journal.